High-Dose Convalescent Plasma for Treatment of Severe COVID-19

/in /by

D. Focosi and A. Casadevall

You might also like
Viral Hepatitis E Outbreaks in Refugees and Internally Displaced Populations, sub-Saharan Africa, 2010–2020
Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021
SURG-3710 – USA (Ohio) – Medical Supplies – Deadline March 30,2022
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021
Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020
Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain